These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 27938789)

  • 1. Surveillance of patients with inflammatory bowel disease.
    Yu JX; East JE; Kaltenbach T
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):949-958. PubMed ID: 27938789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
    Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
    Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching.
    Kaltenbach TR; Soetikno RM; DeVivo R; Laine LA; Barkun A; McQuaid KR;
    Gastrointest Endosc; 2017 Dec; 86(6):1107-1117.e1. PubMed ID: 28818507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease.
    Shergill AK; Farraye FA
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):469-81. PubMed ID: 24975537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
    Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
    Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
    Flynn AD; Valentine JF
    Inflamm Bowel Dis; 2018 Jun; 24(7):1440-1452. PubMed ID: 29668929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White light endoscopy versus chromoendoscopy for the detection of dysplasia during inflammatory bowel disease surveillance with colonoscopy.
    Vaziri H; Anderson JC
    Gastroenterology; 2015 Nov; 149(6):1630-2. PubMed ID: 26428464
    [No Abstract]   [Full Text] [Related]  

  • 8. Updates in colorectal cancer screening in inflammatory bowel disease.
    Clarke WT; Feuerstein JD
    Curr Opin Gastroenterol; 2018 Jul; 34(4):208-216. PubMed ID: 29771698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miles to Go on the SCENIC Route: Should Chromoendoscopy Become the Standard of Care in IBD Surveillance?
    Higgins PD
    Am J Gastroenterol; 2015 Jul; 110(7):1035-7. PubMed ID: 26148262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
    Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
    Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonoscopy Surveillance and Management of Dysplasia in Inflammatory Bowel Disease.
    Kaltenbach T; Leite G; Soetikno R
    Curr Treat Options Gastroenterol; 2016 Mar; 14(1):103-14. PubMed ID: 26831293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Sengupta N; Yee E; Feuerstein JD
    Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.
    Clarke WT; Feuerstein JD
    World J Gastroenterol; 2019 Aug; 25(30):4148-4157. PubMed ID: 31435169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromoendoscopy versus standard colonoscopy for detection of nonpolypoid dysplasia in patients with inflammatory bowel disease.
    Sekra A; Schauer C; Mills L; Vandal AC; Rose T; Lal D; Ogra R
    N Z Med J; 2018 Jul; 131(1478):32-38. PubMed ID: 30001304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of nonpolypoid (flat and depressed) colorectal neoplasms in screening for CRC in patients with IBD.
    Rutter MD
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):327-35. PubMed ID: 24975524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.
    Laine L; Kaltenbach T; Barkun A; McQuaid KR; Subramanian V; Soetikno R;
    Gastroenterology; 2015 Mar; 148(3):639-651.e28. PubMed ID: 25702852
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease.
    Shah SA; Rubin DT; Farraye FA
    Curr Gastroenterol Rep; 2014 Sep; 16(9):407. PubMed ID: 25113042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling cancer in IBD: screening colonoscopy or chromoendoscopy.
    Repici A; Laterra MA; Cisaro F; Pellicano R; Fini L; Ishaq S
    Curr Drug Targets; 2012 Sep; 13(10):1268-72. PubMed ID: 22664084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease.
    Soetikno R; Sanduleanu S; Kaltenbach T
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):483-520. PubMed ID: 24975538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
    Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
    Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.